4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-18-017864
President and General Counsel sold 700 shares at $20.45 ($14,315)
- President and General Counsel acquired 700 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shandell Jason B. President and General Counsel | 2018-03-13 | Option exercise | +300 | $11.79 | $3,537 | 217,248 | D |
| Shandell Jason B. President and General Counsel | 2018-03-13 | Sale | −300 | $20.45 | $6,135 | 216,948 | D |
| Shandell Jason B. President and General Counsel | 2018-03-14 | Option exercise | +400 | $11.79 | $4,716 | 217,348 | D |
| Shandell Jason B. President and General Counsel | 2018-03-14 | Sale | −400 | $20.45 | $8,180 | 216,948 | D |
| Derivatives | |||||||
| Shandell Jason B. President and General Counsel | 2018-03-13 | Option exercise · Employee Stock Option (right to buy) | −300 | 5,700 | D | ||
| Shandell Jason B. President and General Counsel | 2018-03-14 | Option exercise · Employee Stock Option (right to buy) | −400 | 5,300 | D | ||
| Open-market sales · 700 sh · avg $20.45 · $14,315 | |||||||
Loading xslF345X03/a4.xml…